Tevogen Bio Holdings Inc.
TVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,727 | -$60,478 | -$22,041 | -$15,597 |
| Dep. & Amort. | $404 | $378 | $231 | $9 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $40,764 | $0 | $4,579 | $582 |
| Change in WC | -$5 | $293 | -$97 | -$1,249 |
| Other Non-Cash | -$39,434 | $51,635 | $8,673 | $10,979 |
| Operating Cash Flow | -$11,999 | -$8,171 | -$8,656 | -$5,275 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$133 | -$479 | -$110 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$133 | -$479 | -$110 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,000 | $4,000 | $7,500 | $12,500 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$342,984 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $11,229 | $342,857 | $0 | $0 |
| Financing Cash Flow | $12,229 | $3,872 | $7,500 | $12,500 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $231 | -$4,432 | -$1,635 | $7,115 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,052 | $5,484 | $7,119 | $4 |
| End Cash | $1,283 | $1,052 | $5,484 | $7,119 |
| Free Cash Flow | -$11,999 | -$8,304 | -$9,135 | -$5,385 |